Skip to content

Data Collection on ReCap/Magnum in Total Hip Replacement and Resurfacing

A Prospective, Multicentre Study Evaluating the Clinical Performance of the ReCap/Magnum in Total Hip Replacement and Resurfacing

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00758355
Enrollment
150
Registered
2008-09-25
Start date
2008-03-31
Completion date
2016-06-30
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Resurfacing

Brief summary

Observational study on ReCap/Magnum in Total Hip Replacement and Resurfacing.

Detailed description

This observational study intends to collect efficacy and safety data on ReCap/Magnum in Total Hip Replacement and Resurfacing.

Interventions

None listed

Sponsors

Biomet France SARL
CollaboratorINDUSTRY
Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Consecutive series of patients received Total Hip Replacement or Resurfacing with ReCap/Magnum for Its Respective Indications for Use/Intended Uses

Design outcomes

Primary

MeasureTime frame
Postel-Merle d'Aubigné (PMA), Harris Hip Score1yr and 2yr

Secondary

MeasureTime frame
ComplicationAny time
Survival1yr and 2yr

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026